These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22442117)

  • 1. Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors.
    Chiellini G; Erba P; Carnicelli V; Manfredi C; Frascarelli S; Ghelardoni S; Mariani G; Zucchi R
    J Endocrinol; 2012 Jun; 213(3):223-30. PubMed ID: 22442117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution and cardiac metabolism of 3-iodothyronamine.
    Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R
    Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human TAAR8 and murine Taar8b mediated signaling pathways and expression profile.
    Mühlhaus J; Dinter J; Nürnberg D; Rehders M; Depke M; Golchert J; Homuth G; Yi CX; Morin S; Köhrle J; Brix K; Tschöp M; Kleinau G; Biebermann H
    Int J Mol Sci; 2014 Nov; 15(11):20638-55. PubMed ID: 25391046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
    Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
    J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity.
    Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N
    Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926
    [No Abstract]   [Full Text] [Related]  

  • 6. Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5.
    Dinter J; Mühlhaus J; Wienchol CL; Yi CX; Nürnberg D; Morin S; Grüters A; Köhrle J; Schöneberg T; Tschöp M; Krude H; Kleinau G; Biebermann H
    PLoS One; 2015; 10(2):e0117774. PubMed ID: 25706283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
    Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
    Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines.
    Chiellini G; Bellusci L; Sabatini M; Zucchi R
    Mol Cell Endocrinol; 2017 Dec; 458():149-155. PubMed ID: 28069535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function.
    Chiellini G; Frascarelli S; Ghelardoni S; Carnicelli V; Tobias SC; DeBarber A; Brogioni S; Ronca-Testoni S; Cerbai E; Grandy DK; Scanlan TS; Zucchi R
    FASEB J; 2007 May; 21(7):1597-608. PubMed ID: 17284482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors.
    Biebermann H; Kleinau G
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):395-400. PubMed ID: 31698479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors.
    Laurino A; Matucci R; Vistoli G; Raimondi L
    Eur J Pharmacol; 2016 Dec; 793():35-42. PubMed ID: 27815171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of 3-iodothyronamine (3-T
    Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine.
    Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L
    Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells.
    Agretti P; De Marco G; Russo L; Saba A; Raffaelli A; Marchini M; Chiellini G; Grasso L; Pinchera A; Vitti P; Scanlan TS; Zucchi R; Tonacchera M
    J Mol Endocrinol; 2011 Aug; 47(1):23-32. PubMed ID: 21511808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.
    Dinter J; Mühlhaus J; Jacobi SF; Wienchol CL; Cöster M; Meister J; Hoefig CS; Müller A; Köhrle J; Grüters A; Krude H; Mittag J; Schöneberg T; Kleinau G; Biebermann H
    J Mol Endocrinol; 2015 Jun; 54(3):205-16. PubMed ID: 25878061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on 3-iodothyronamine and its neurological and metabolic actions.
    Zucchi R; Accorroni A; Chiellini G
    Front Physiol; 2014; 5():402. PubMed ID: 25360120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern.
    Mariotti V; Melissari E; Iofrida C; Righi M; Di Russo M; Donzelli R; Saba A; Frascarelli S; Chiellini G; Zucchi R; Pellegrini S
    PLoS One; 2014; 9(11):e106923. PubMed ID: 25379707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.
    Chiellini G; Nesi G; Digiacomo M; Malvasi R; Espinoza S; Sabatini M; Frascarelli S; Laurino A; Cichero E; Macchia M; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
    J Med Chem; 2015 Jun; 58(12):5096-107. PubMed ID: 26010728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
    Rutigliano G; Bandini L; Sestito S; Chiellini G
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.
    Landucci E; Gencarelli M; Mazzantini C; Laurino A; Pellegrini-Giampietro DE; Raimondi L
    Neurochem Int; 2019 Oct; 129():104460. PubMed ID: 31075293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.